You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nontuberculous Mycobacteriam Infection

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Transmission and Acquisition of Nontuberculous Mycobacteria

Recruiting
  • Nontuberculous Mycobacterial Pulmonary Infection
  • +3 more
  • Epidemiologic investigation
  • Denver, Colorado
    National Jewish Health
Dec 1, 2023

Prospective Healthcare-Associated Links in Transmission of

Enrolling by invitation
  • Cystic Fibrosis
  • Nontuberculous Mycobacterial Pulmonary Infection
    • Denver, Colorado
      National Jewish Health
    Jan 6, 2023

    Expectorated and Induced Sputum and Pharyngeal Swabs for

    Completed
    • Myobacterium Infections, Nontuberculous
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      Mycobacterium Avium Complex Pulmonary Disease Trial (Minocycline)

      Not yet recruiting
      • Mycobacterium Avium Complex Pulmonary Disease
      • (no location specified)
      May 15, 2023

      Healthcare-associated Links in Transmission of Nontuberculous

      Recruiting
      • Cystic Fibrosis
      • Nontuberculous Mycobacterium Infection
      • Epidemiologic investigation
      • Denver, Colorado
        National Jewish Health
      Apr 6, 2022

      Nontuberculous Mycobacterium Infection, Mycobacterium Abscessus Infection Trial (Delpazolid)

      Not yet recruiting
      • Nontuberculous Mycobacterium Infection
      • Mycobacterium Abscessus Infection
      • (no location specified)
      Aug 21, 2023

      Mycobacterium Abscessus Infection in Chronic Lung Disease and

      Enrolling by invitation
      • Mycobacterium Abscessus Infection
      • +2 more
      • Appropriate treatment
      • Pathum Wan, Bangkok, Thailand
        King Chulalongkorn Memorial Hospital
      Aug 31, 2022

      Mycobacterium Infections, Nontuberculous, Mycobacterium Abscessus Infection, Nontuberculous Mycobacterial Lung Disease Trial in

      Recruiting
      • Mycobacterium Infections, Nontuberculous
      • +3 more
      • Omadacycline Oral Tablet
      • Placebo
      • Birmingham, Alabama
      • +20 more
      Jan 11, 2023

      Cross-sectional Characterization of Idiopathic Bronchiectasis

      Completed
      • Infection
      • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 7, 2023

        Nontuberculous Mycobacterial Lung Disease, Nontuberculous Mycobacterium Infection Trial in New York, Portland, Toronto

        Recruiting
        • Nontuberculous Mycobacterial Lung Disease
        • Nontuberculous Mycobacterium Infection
        • Hypertonic saline
        • +3 more
        • New York, New York
        • +2 more
        Jan 27, 2023

        Mycobacterium Infections, Nontuberculous, Cystic Fibrosis (CF) Trial in United States (Molgramostim nebulizer solution, PARI

        Terminated
        Has Results
        • Mycobacterium Infections, Nontuberculous
        • Cystic Fibrosis (CF)
        • Molgramostim nebulizer solution
        • PARI eFlow nebulizer system
        • Denver, Colorado
        • +4 more
        Oct 10, 2021

        Tuberculosis, Latent Tuberculosis, Nontuberculous Mycobacterium Infection Trial in Busan (therapeutic drug monitoring(TDM))

        Recruiting
        • Tuberculosis
        • +2 more
        • therapeutic drug monitoring(TDM)
        • Busan, Korea, Republic of
          Inje University Busan Paik Hoapital Clinical Trial Center
        Mar 6, 2022

        PK and PD of Antibiotics for Treatment of Mycobacterium

        Not yet recruiting
        • Nontuberculous Mycobacterial Pulmonary Infection
        • Measuring PK and PD indices in patients who receive conventional treatment
        • (no location specified)
        Dec 22, 2022

        Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) Trial (Placebo, SPR720 500 mg, SPR720 1000 mg)

        Not yet recruiting
        • Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)
        • Placebo
        • +2 more
        • (no location specified)
        Aug 9, 2022

        Nontuberculous Mycobacterium Infection Trial in United States (Gallium nitrate)

        Recruiting
        • Nontuberculous Mycobacterium Infection
        • Gallium nitrate
        • Birmingham, Alabama
        • +8 more
        Jan 10, 2023

        Mycobacterium Infections, Nontuberculous Trial in Australia, United Kingdom (Inhaled molgramostim)

        Completed
        • Mycobacterium Infections, Nontuberculous
        • Inhaled molgramostim
        • Concord, New South Wales, Australia
        • +4 more
        Mar 23, 2021

        Cystic Fibrosis Trial in Aurora (Ethambutol, Rifampin, Azithromycin)

        Completed
        Has Results
        • Cystic Fibrosis
        • Aurora, Colorado
          Children's Hospital Colroado
        Jan 20, 2021

        Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)

        Active, not recruiting
        • Mycobacterium Infections, Nontuberculous
        • Birmingham, Alabama
        • +110 more
        Jan 23, 2023

        Nontuberculous Mycobacterium Infection Trial in Portland, Charleston (gNO)

        Completed
        Has Results
        • Nontuberculous Mycobacterium Infection
        • Portland, Oregon
        • +1 more
        May 17, 2021

        Non-Tuberculous Mycobacterial Pneumonia, Cystic Fibrosis, Mycobacterial Pneumonia Trial in Greenslopes (LungFit)

        Recruiting
        • Non-Tuberculous Mycobacterial Pneumonia
        • +4 more
        • LungFit
        • Greenslopes, Queensland, Australia
          Gallipoli Medical Research Foundation
        Dec 24, 2020

        Mycobacterium Avium Complex, Nontuberculous Mycobacterium Infection Trial in Canada, United States (Azithromycin, Ethambutol,

        Recruiting
        • Mycobacterium Avium Complex
        • Nontuberculous Mycobacterium Infection
        • Loma Linda, California
        • +26 more
        Jan 18, 2023

        Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)

        Recruiting
        • Mycobacterium Infections, Nontuberculous
        • Birmingham, Alabama
        • +172 more
        Jan 23, 2023

        Mycobacterium Infections, Nontuberculous Trial (LAI (Liposomal Amikacin for Inhalation) 590 mg)

        Completed
        Has Results
        • Mycobacterium Infections, Nontuberculous
        • LAI (Liposomal Amikacin for Inhalation) 590 mg
        • (no location specified)
        Apr 22, 2020

        Non-Tuberculous Mycobacterial Pneumonia Trial in Vancouver (Nitric Oxide gas at 160ppm)

        Completed
        • Non-Tuberculous Mycobacterial Pneumonia
        • Nitric Oxide gas at 160ppm
        • Vancouver, British Columbia, Canada
          Gordon Leslie Diamond Health Care Centre
        Jul 27, 2020

        Drug Exposure and Minimum Inhibitory Concentration in Treatment

        Not yet recruiting
        • Mycobacterium Avium Complex
        • +3 more
        • Drug exposure
        • Shanghai, China
          Shanghai Pulmonary Hospital
        Apr 10, 2023